HealthEquity, Inc. (NASDAQ:HQY) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

HealthEquity, Inc. (NASDAQ:HQYGet Free Report) has received an average rating of “Moderate Buy” from the fifteen analysts that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, twelve have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $111.7857.

HQY has been the subject of a number of research analyst reports. Barrington Research dropped their price objective on shares of HealthEquity from $125.00 to $110.00 and set an “outperform” rating for the company in a research note on Wednesday, March 18th. JPMorgan Chase & Co. dropped their price objective on shares of HealthEquity from $129.00 to $123.00 and set an “overweight” rating for the company in a research note on Wednesday, March 18th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research note on Thursday, March 19th. BTIG Research dropped their target price on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a research report on Tuesday, February 17th. Finally, Raymond James Financial set a $100.00 target price on shares of HealthEquity in a research report on Tuesday, February 17th.

Read Our Latest Report on HealthEquity

HealthEquity Trading Up 1.9%

NASDAQ HQY opened at $84.65 on Wednesday. HealthEquity has a 12 month low of $72.76 and a 12 month high of $116.65. The company has a 50-day moving average of $81.98 and a 200-day moving average of $87.07. The company has a debt-to-equity ratio of 0.45, a current ratio of 3.27 and a quick ratio of 3.27. The company has a market cap of $7.10 billion, a P/E ratio of 34.41, a P/E/G ratio of 1.51 and a beta of 0.19.

HealthEquity (NASDAQ:HQYGet Free Report) last posted its quarterly earnings data on Tuesday, March 17th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.05. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The company had revenue of $334.59 million during the quarter, compared to the consensus estimate of $332.48 million. The business’s quarterly revenue was up 7.3% on a year-over-year basis. As a group, equities analysts predict that HealthEquity will post 3.84 earnings per share for the current year.

Institutional Trading of HealthEquity

Institutional investors and hedge funds have recently bought and sold shares of the business. Capricorn Fund Managers Ltd acquired a new stake in HealthEquity during the 4th quarter worth approximately $6,926,000. 12th Street Asset Management Company LLC increased its position in HealthEquity by 114.4% during the 3rd quarter. 12th Street Asset Management Company LLC now owns 272,068 shares of the company’s stock worth $25,784,000 after purchasing an additional 145,151 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in HealthEquity by 45.5% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 155,543 shares of the company’s stock worth $14,741,000 after acquiring an additional 48,621 shares during the period. Bessemer Group Inc. boosted its holdings in HealthEquity by 21.3% in the 3rd quarter. Bessemer Group Inc. now owns 349,342 shares of the company’s stock worth $33,108,000 after acquiring an additional 61,317 shares during the period. Finally, JPMorgan Chase & Co. boosted its holdings in HealthEquity by 11.5% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,205,077 shares of the company’s stock worth $114,205,000 after acquiring an additional 124,283 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

(Get Free Report)

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.

Featured Stories

Analyst Recommendations for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.